Navigation Links
China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Date:9/10/2007

HARBIN, China, Sept. 10 /Xinhua-PR Newswire-FirstCall/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products, announced today that the Company plans to launch a new product: Cactus Health Cigarettes.

In order to develop a niche market, to welcome the green-themed 2008 Beijing Olympiad, and in an effort to take advantage of the public's increasing health awareness stimulated by this event, the Company has successfully researched and developed a smoking product that uses cactus as its main ingredient: Cactus Health Cigarettes. The Company has applied for patent protection for the product at the China National Bureau of Intellectual Property and expects to gain approval before the end of the year. The Company believes that this product has huge market potential and that the sales of the product could have an extremely positive impact on Company's top and bottom lines. The Company has decided to launch the product in 2008.

Cactus Health Cigarettes

This product uses dried cactus palms as the main ingredient, together with dried honeysuckle, dried ginkgo leaves, and a small amount of a plant based essence, and is made through conventional cigarette production processes and technologies. This product is a new and healthy alternative to conventional cigarettes.

The harmful effects of cigarette smoking and the difficulty to quit smoking are well known. Cigarette production and consumption are especially high in China. Large numbers of people die every year due to traditional nicotine cigarette-related diseases, and many also suffer from illnesses related to second-hand smoke. The launch of cactus health cigarettes is a Gospel to those who suffer miserably from smoking.

According to The Grand Dictionary of Chinese Medicine and the Compendium of Materia Medica, as well as many certified tests and analyses carried out by the Department of Agriculture and the Institute for Nutrition and Food Safety of the Center of Disease Prevention and Control of China, cacti contain over 18 kinds of amino acid, carbohydrates, chief meal fibrin, carotene, vitamin C, vitamin E, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, smoke acid, folacin, calcium, phosphorus, iron, potassium, sodium, magnesium, manganese, copper, zinc, iodine, and selenium. Various cactus products have been shown to provide health benefits and have been used to treat a variety of health issues including, diabetes, adiposity, constipation, cholesterol, high blood pressure, low immunity, and various skin disorders.

China Kangtai owns nearly 400 acres of farmland and grows three species of Mexican cacti and some of the Company's own cloned species. The Company owns an R & D institute that has successfully produced 31 product patents, 15 of which have already been approved. It currently produces and sells four cactus- based product categories: nutraceuticals, which are health and wellness dietary supplements; beverages, including juice, teas, beer, wine, and spirits; packaged foods, such as noodles, biscuits and pickles; and raw and intermediate cactus materials. There are about 36 existing products under these four categories.

Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, "Cactus-based products are well-received by the market in China and show huge growth potential. China Kangtai will continue to develop new products to meet the demand of the consumers, while penetrating the markets with its existing products."

Wang concluded, "Our Company remains focused on the quality and functionality of our products that deliver various health benefits to consumers. These new products will contribute positively to the Company's 2007 performance and beyond, and accelerate its revenue and profit growth. With 15 product patents and 16 pending approval, China Kangtai is the dominant player in the cactus-based consumer product sector."

About China Kangtai Cactus Bio-Tech Inc.

China Kangtai Cactus Bio-Tech, Inc. is a market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 15 product patents and is seeking another 16 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 14 provinces and 4 municipalities.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information about China Kangtai Cactus Bio-tech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Bio-tech future performance, operations and products.

This forward-looking information should be considered only in connection with "Risk Factors" in China Kangtai Cactus Bio-tech's annual report on Form 10KSB filed with the SEC on April 2, 2007, and its other current and periodic reports filed with the SEC. China Kangtai Cactus Bio-tech assumes no obligations to update any forward-looking statements or information set forth in this press release.

For more information, please contact:

At the Company:

Ren Hu

Vice President

China Kangtai Cactus Bio-tech, Inc.

Phone: +1-201-887-0415

Email: Arenhu@gmail.com

Investor Relations:

RedChip Companies, Inc.

Jon Cunningham

Phone: +1-800-RedChip x107

Email: Jon@RedChip.com / Info@RedChip.com

Website: http://www.RedChip.com


'/>"/>
SOURCE China Kangtai Cactus Bio-tech, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. How do you level the playing field with China?
2. State of biotech, medical device sector is focus of upcoming conference
3. In Globalizing Biotech, Midwest Must Differentiate From Pack
4. Forbes highlights Wisconsin biotech, names Madison #1 business city
5. Speaker announces business members of IT Task Force
6. Doyle announces technology tax credits for Berbee
7. Doyle announces new energy, global warming policies
8. Doyle announces $80M renewable energy strategy
9. GE announces first installation of Discovery VCT
10. UWM announces winners of RGI awards
11. Third Wave announces two senior management appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
(Date:1/18/2017)... According to a new market research report "In situ Hybridization Market ... User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to 2021" ... 2021 from USD 557.1 Million in 2016, growing at a CAGR of 5.8%. ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... ... 18, 2017 , ... Executive search firm Slone Partners proudly ... to the advancement of the clinical trials segment. Hosted in Miami, this conference ... planning and management. , As executive talent specialists in the industries central ...
Breaking Biology Technology:
(Date:12/22/2016)... YORK , December 22, 2016 ... provider of secure solutions for the e-Government, Public Safety, HealthCare, and ... subsidiary of SuperCom, has been selected to implement and deploy a ... in Northern California , further expanding its presence ... ...
(Date:12/16/2016)... , Dec. 16, 2016   IdentyTechSolutions ... Identity management products and solutions and a cutting-edge ... today that it is offering seamless, integrated solutions ... security entrance products. The solutions provide IdentyTech,s customers ... secure their facilities from crime and theft. ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):